William Blair Investment Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.9M | Sell |
14,642,157
-136,494
| -0.9% | -$782K | 0.22% | 111 |
|
|
2025
Q1 | $121M | Sell |
14,778,651
-819,047
| -5% | -$6.68M | 0.34% | 84 |
|
|
2024
Q4 | $147M | Buy |
15,597,698
+14,736
| +0.1% | +$139K | 0.36% | 90 |
|
|
2024
Q3 | $166M | Buy |
15,582,962
+2,579,599
| +20% | +$27.6M | 0.41% | 83 |
|
|
2024
Q2 | $129M | Buy |
13,003,363
+1,477,084
| +13% | +$14.7M | 0.34% | 91 |
|
|
2024
Q1 | $136M | Sell |
11,526,279
-120,747
| -1% | -$1.42M | 0.35% | 88 |
|
|
2023
Q4 | $165M | Buy |
11,647,026
+1,270,263
| +12% | +$18M | 0.48% | 68 |
|
|
2023
Q3 | $126M | Buy |
10,376,763
+8,070,098
| +350% | +$98.1M | 0.42% | 78 |
|
|
2023
Q2 | $29M | Buy |
2,306,665
+25,573
| +1% | +$321K | 0.09% | 237 |
|
|
2023
Q1 | $25.3M | Buy |
2,281,092
+179,906
| +9% | +$2M | 0.09% | 242 |
|
|
2022
Q4 | $25.7M | Buy |
2,101,186
+15,822
| +0.8% | +$193K | 0.1% | 229 |
|
|
2022
Q3 | $21.8M | Sell |
2,085,364
-462,242
| -18% | -$4.83M | 0.09% | 246 |
|
|
2022
Q2 | $27.4M | Buy |
2,547,606
+16,194
| +0.6% | +$174K | 0.1% | 222 |
|
|
2022
Q1 | $24M | Buy |
2,531,412
+54,691
| +2% | +$518K | 0.07% | 268 |
|
|
2021
Q4 | $28.6M | Buy |
2,476,721
+501,749
| +25% | +$5.8M | 0.08% | 258 |
|
|
2021
Q3 | $18.9M | Buy |
1,974,972
+23,295
| +1% | +$222K | 0.05% | 320 |
|
|
2021
Q2 | $18.8M | Buy |
1,951,677
+790,953
| +68% | +$7.62M | 0.06% | 228 |
|
|
2021
Q1 | $11.5M | Buy |
1,160,724
+89,073
| +8% | +$880K | 0.04% | 270 |
|
|
2020
Q4 | $24.7M | Buy |
1,071,651
+105,888
| +11% | +$2.44M | 0.08% | 185 |
|
|
2020
Q3 | $13.6M | Buy |
+965,763
| New | +$13.6M | 0.05% | 233 |
|